Prof. Dr. Çetin KARACA

Yayın Ağı

Makaleler 27

1. Should we worry about incidental gastrointestinal tract involvement in positron emission tomography/computed tomography as gastroenterologist?

Iliaz R., Cavus B., Yegen G., Alcin G., Gulluoglu M., Karaca C., et al.

Acta gastro-enterologica Belgica , cilt.81, sa.4, ss.471-475, 2018 (SCI-Expanded)

2. Cyclosporine therapy is effective in acute severe steroid-refractory ulcerative colitis

Iliaz R., Evirgen S., Akyuz F., Cavus B., Pinarbasi B., Karaca C., et al.

JOURNAL OF CROHNS & COLITIS , 2016 (SCI-Expanded)

3. MICROSCOPIC COLITIS IN PATIENTS WITH TAKAYASU'S ARTERITIS: A POTENTIAL ASSOCIATION BETWEEN THE TWO DISEASE ENTITIES

Alpay-Kanitez N., Tozl B., Gulluoglu M., Erer B., Inanc M., Iliaz R., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.74, ss.1119, 2015 (SCI-Expanded)

4. Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B

Koklu S., Gulsen M. T., Tuna Y., Koklu H., Yuksel O., Demir M., et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS , cilt.41, sa.3, ss.310-319, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

5. Isoniazid prophylaxis may not prevent tuberculosis reactivation during anti-TNF treatment

Akyuz F., Iliaz R., Evirgen S., Onder S. Y., Koksalan K., Karaca C., et al.

JOURNAL OF CROHNS & COLITIS , 2015 (SCI-Expanded)

6. Irritable bowel syndrome may overlap the other digestive symptoms

Akyuz F., Obekli T., Akyuz U., Iliaz I., Gokturk S., Evirgen S., et al.

NEUROGASTROENTEROLOGY AND MOTILITY , ss.72, 2014 (SCI-Expanded)

7. Esophageal dysmotility: think about in diabetes mellitus patients

Gokturk S., Akyuz U., Akyuz F., Gul N., Iliaz R., Karaca C., et al.

NEUROGASTROENTEROLOGY AND MOTILITY , ss.64, 2014 (SCI-Expanded)

8. Does Lapatinip Increase Pulmonary Toxicity When Concurrently Used with Radiation Therapy? An Experimental Study with Wistar-Albino Rats.

Senel B. N., Yetmen O., Guzel E., Karaca C., Coban I., Elicin O., et al.

CANCER RESEARCH , cilt.71, 2011 (SCI-Expanded)

9. Does lapatinib increase pulmonary toxicity when concurrently used with radiation therapy? An experimental study with Wistar albino rats

Elicin O., Bese N. S., Yetmen O., Guzel E., Eser M., Karaca C., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.29, sa.15, 2011 (SCI-Expanded)

10. Is HCV Genotyping Cost-Effective Even When the Prevalences of Genotypes 2 and 3 are Low?

Tahan V., Ozaras R., Karaca C., Uraz S., EREN F., Danalioglu A., et al.

HEPATO-GASTROENTEROLOGY , cilt.56, ss.1425-1428, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

11. The Effects of Nitric Oxide Donor Molsidomine on Skeletal Muscle Damage in a Rat Hind Limb Model of Ischemia-Reperfusion

Oeztuerk K., Ozyurt H., Somay A., Karaca C.

EUROPEAN SURGICAL RESEARCH , cilt.42, sa.2, ss.71-77, 2009 (SCI-Expanded)

12. Retina derived relaxation is preserved in carotid and mesenteric arteries of diabetic rats

Agus M., Takir S., Uydes-Dogan B. S., Karaca C., Altug T., Ozdemir O.

FUNDAMENTAL & CLINICAL PHARMACOLOGY , cilt.22, ss.81, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

13. Crataegus microphylla improves endothelial dysfunction in streptozotocin-induced diabetic rats

Koc E., Topal G., Dogan B. S., Melikoglu G., Mericli A. H., Karaca C., et al.

FUNDAMENTAL & CLINICAL PHARMACOLOGY , cilt.22, ss.66, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

14. Risk factors for the transmission of hepatitis C virus infection in the Turkish population

Karaca C., Cakaloglu Y., Demir K., Ozdil S., Kaymakoglu S., Badur S., et al.

DIGESTIVE DISEASES AND SCIENCES , cilt.51, sa.2, ss.365-369, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

15. Sexual transmission of HCV between spouses

Tahan V., Karaca C., Yildirim B., Bozbaş A., Ozaras R., Demir K., et al.

American Journal of Gastroenterology , cilt.100, sa.4, ss.821-824, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

16. Pneumatic balloon dilatation in primary achalasia: The long-term follow-up results

Boztas G., Mungan Z., Ozdil S., Akyuz F., Karaca C., Kaymakoglu K., et al.

HEPATO-GASTROENTEROLOGY , cilt.52, sa.62, ss.475-480, 2005 (SCI-Expanded)

17. Alpha interferon and ribavirin combination therapy of chronic hepatitis D

Kaymakoglu S., Karaca C., Demir K., Poturoglu S., Danalioglu A., Badur S., et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , cilt.49, sa.3, ss.1135-1138, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

18. Ribavirin treatment in patients with chronic hepatitis C infection who had renal transplantation

Karaca C., Besisik F., Akyuz F., Dincer D., Sever M., Okten A.

DIGESTIVE SURGERY , cilt.22, ss.113, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

19. Efficacy of alpha interferon therapy for lamivudine resistance in chronic hepatitis B

Danalioglu A., Kaymakoglu S., Cakaloglu Y., Demir K., Karaca C., Durakoglu Z., et al.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.58, sa.7, ss.659-661, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma

20. Intra-articular injection of tenoxicam in rats: Assessment of the local effects on the articular cartilage and synovium

Ozyuvaci H., Bilgic B., Ozyuvaci E., Altan A., Altug T., Karaca C.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH , cilt.32, sa.3, ss.312-316, 2004 (SCI-Expanded)

21. Ulcerative colitis: Analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?)

Ozdil S., Akyuz F., Pinarbasi B., Demir K., Karaca C., Boztas G., et al.

HEPATO-GASTROENTEROLOGY , cilt.51, sa.57, ss.768-770, 2004 (SCI-Expanded)

22. Intestinal bacterial overgrowth in liver cirrhosis: Is it a predisposing factor for spontaneous ascitic infection?

Karaca C., Kaymakoglu S., Uyar A., Karayay S., Gurler N., Demir K., et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY , cilt.97, sa.7, ss.1851, 2002 (SCI-Expanded)

23. Long-term results of alpha interferon therapy in anti-HBe(+) chronic hepatitis B.

Kaymakoglu S., Demir K., Cakaloglu Y., Durakoglu Z., Karaca C., Danalioglu A., et al.

HEPATOLOGY , cilt.34, sa.4, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

24. Interferon alpha-2b plus ribavirin for chronic hepatitis C in primary nonresponders to interferon alone

Demir K., Kaymakoglu S., Dincer D., Tuncer I., Durakoglu Z., Karaca C., et al.

JOURNAL OF HEPATOLOGY , cilt.34, ss.171, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

25. Lamivudine and alpha interferon combination therapy in patients with anti-HBe-positive chronic hepatitis B: Preliminary results of a randomised study

Kaymakoglu S., Demir K., Cakaloglu Y., Durakoglu Z., Dincer D., Karaca C., et al.

JOURNAL OF HEPATOLOGY , cilt.34, ss.171, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

26. Ascitic fluid cholesterol level in the diagnosis of postsinusoidal portal hypertension

Demir K., Kaymakoglu S., Ozdil S., Dincer D., Durakoglu Z., Karaca C., et al.

JOURNAL OF HEPATOLOGY , cilt.34, ss.230, 2001 (SCI-Expanded)

27. Lessons should be taken from 60 complete remission patients with type I diabetes

Yilmaz M., Satman I., Karsidag K., Dinccag N., Karaca C., Sargin M., et al.

DIABETOLOGIA , cilt.40, ss.372, 1997 (SCI-Expanded) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 19

1. Psoriasis and Neutrophilic Cholangitis: More Than A Coincidence

ÖZARAS R., Bedavalar S., Engin B., KUTLUBAY Z., Kepil N., Seyahi E., et al.

The 25th Conference of the Asian Pacific Association for the Study of the Liver (APASL), Tokyo, Japonya, 20 - 24 Şubat 2016, cilt.1, ss.1, (Tam Metin Bildiri)

2. Sistem temelli entegre tıp eğitiminde canlı videokonferans yöntemiyle anatomi eğitiminin dikey entegrasyonu: Canlı Anatomi.

GÜRSES İ. A., ŞANLI M. Ö., AKYÜZ F., KALE A., BARBAROS N. U., KARACA Ç., et al.

Prof. Dr. İbrahim Veli Odar Anatomi Kış Toplantısı, Kastamonu, Türkiye, 11 - 14 Şubat 2016, ss.29, (Özet Bildiri)

3. COMPARISON OF PROGNOSTIC SCORING SYSTEMS FOR PREDICTION OF SURVIVAL IN HEPATOCELLULAR CARCINOMA

Baran B., Ekinci O., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., et al.

EASL International Liver Congress, Barcelona, İspanya, 13 - 17 Nisan 2016, (Özet Bildiri) Sürdürülebilir Kalkınma

4. Belching in irritable bowel syndrome: an impedance study

Akyuz F., Obekli T., Iliaz R., Arici S., Gokturk S., Karaca C., et al.

NeuroGASTRO Conference, İstanbul, Türkiye, 4 - 06 Haziran 2015, ss.38-39, (Özet Bildiri)

5. The frequency of gastro-esophageal reflux disease in patients with mild-moderate stage chronic obstructive lung disease (COPD) and its relationship with acute exacerbations of COPD

Iliaz S., Akyuz F., Onur S. T., Akyuz U., Karaca C., Demir K., et al.

NeuroGASTRO Conference, İstanbul, Türkiye, 4 - 06 Haziran 2015, ss.70, (Özet Bildiri)

6. Prevalence of unrecognized celiac disease in couples with unexplained infertility

Karaca N., Yilmaz R., Aktun L., Batmaz G., Karaca C.

31st Annual Meeting of the European-Society-of-Human-Reproduction-and-Embryology (ESHRE), Lisbon, Portekiz, 14 - 17 Haziran 2015, cilt.30, ss.294, (Özet Bildiri)

7. ENTECAVIR AND TENOFOVIR HAVE A COMPARABLE EFFICACY IN TREATMENT OF NUCLEOS(T)IDE ANALOGUE NAIVE PATIENTS WITH CHRONIC HEPATITIS B: A REAL LIFE EXPERIENCE

Baran B., Soyer O. M., Ormeci A., Gokturk S., Evirgen S., Akyuz F., et al.

49th Annual International Liver Congress of the European-Association-for-the-Study-of-the-Liver, London, Kanada, 9 - 13 Nisan 2014, (Özet Bildiri)

8. TREATMENT FAILURE MAY LEAD TO ACCELERATED FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C

Baran B., Gulluoglu M., Soyer O., Ormeci A., Gokturk S., Evirgen S., et al.

International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Amsterdam, Hollanda, 24 - 28 Nisan 2013, (Özet Bildiri)

9. RESPONSE TO TENOFOVIR TREATMENT OF TREATMENT-NAIVE VS ADEFOVIR-RESISTANT VS SUBOPTIMAL RESPONDER PATIENTS WITH CHRONIC HEPATITIS B

Keskin O., Ormeci A., Kabacam G., Akyuz F., Aniktar H., Karaca C., et al.

47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Barcelona, İspanya, 18 - 22 Nisan 2012

10. The effects of concurrent or sequential administration of trastuzumab on radiation-induced pulmonary fibrosis in rats

Umay C., Bese N. S., Serdengecti S., Kepi N., Karaca C., Sut N., et al.

6th European Breast Cancer Conference, Berlin, Almanya, 15 - 19 Nisan 2008, cilt.6, ss.111-112, (Özet Bildiri)

11. Is HCV genotyping cost-effective in Turkey?

Tahan V., ÖZARAS R., Uraz S., KARACA Ç., Eren F., Danalioglu A., et al.

17th APASL Conference, Kyoto, Japonya, 27 - 30 Mart 2007, cilt.1, ss.139, (Tam Metin Bildiri)

12. Are there any noninvasive markers for diagnosis of viral hepatitis?

Aydin Z., Demir K., Okten A., Kaymakoglu S., Salmayenli N., Ozdil S., et al.

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, ss.110, (Özet Bildiri)

13. Time to development of chronic liver diseases in a genotype 1 dominant population of chronic hepatitis C virus infection

Karaca C., Cakalogu Y., Demir K., Ozdil S., Kaymakoglu S., Badur S., et al.

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.148-149, (Özet Bildiri) Sürdürülebilir Kalkınma

14. Are ascitic fluid cholesterol and ratio of ascites/serum cholesterol able to reflect hepatic sinusoidal capillarization?

Demir K., Karaca C., Kaymakoglu S., Ozdil S., Besisik F., Boztas G., et al.

38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver, İstanbul, Türkiye, 29 Mart - 01 Nisan 2003, cilt.38, ss.57-58, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

272

H-İndeks (WoS)

Atıf (Scopus)

299

H-İndeks (Scopus)

BM Sürdürülebilir Kalkınma Amaçları